Clinical trials

  • OLAPARIB for BRCA-mutated advanced ovarian cancer (FIGO stage III-IV)
  • ENPATORAN for Subacute cutaneous lupus erythematosus | Discoid lupus erythematosus | Systemic lupus erythematosus
  • IMATINIB for Primary breast cancer | Triple-negative breast cancer
  • MITOMYCIN for Non-muscle invasive bladder cancer | Non-muscle invasive urothelial carcinoma
  • Durvalumab for Non-small cell lung cancer (synchronous oligometastatic)
  • SENICAPOC for Progressive fibrotic interstitial lung disease | Idiopathic pulmonary fibrosis
  • Atezolizumab for Urothelial carcinoma | Muscle-invasive bladder cancer | Metastatic bladder cancer
  • CRIZOTINIB for Solid tumor
  • Cabozantinib for Neuroendocrine neoplasia | Neuroendocrine tumor
  • ATORVASTATIN for Melanoma | Atherosclerosis
  • SOLRIKITUG for Eosinophilic esophagitis
  • Inclisiran (inclisiran sodium) for Non-obstructive coronary artery disease